Group items tagged

Acceptable samples collected from throat (oropharyngeal) swabs, nasopharyngeal swabs, anterior nasal swabs, mid-turbinate nasal swabs, nasal washes, nasal aspirates and bronchoalveolar lavage fluid (BALF)

BGI Genomics Sees Diagnostics Core Business Rebounding, Overseas Business Growing | Genomeweb

China's top gene-sequencing provider BGI will participate in the Genome Program, which aims to use genomic data to improve health outcomes in the United Arab Emirates (UAE), the company announced Wednesday.

Natera and BGI Genomics Announce $50M Partnership to Commercialize Signatera Oncology Test in China and to Develop Reproductive Health Tests in Select Markets on BGI's DNBseq™ Technology Platform | Natera

Beijing Genomics Institute (BGI)'s First BGISEQ-500 in Asia Pacific has Settled in Taiwan

NEW YORK - Chinese diagnostics firm BGI Genomics reported last week that its H1 2021 revenues declined 11 percent due to decreasing demand for COVID-19 testing.

BGI Genomics H1 Revenues Fall 11 Percent on COVID-19 Testing Decline | Genomeweb

Starting up Biology in China: Performances of Life at BGI | Osiris: Vol 33, No 1